Definitive Contract 75D30122C13064
Award Date 12/21/21
Potential Completion Date 6/15/22
Potential Value $4.2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Halethorpe, MD 21227, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) has awarded a $38,760,799.92 firm-fixed-price definitive contract to Verily Life Sciences LLC, a subsidiary of Alphabet Inc., to provide wastewater surveillance testing services. The contract, which has no set-aside designation, will support the CDC's ongoing COVID-19 and monkeypox response efforts, as well as prepare for future public health emergencies. Under the contract, Verily will establish sample collection relationships with wastewater...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $681,553.26 firm fixed-price definitive contract to Aquavitas, LLC, a for-profit limited liability company, for genomic sequencing of wastewater samples and analysis to detect the presence of the SARS-CoV-2 virus. The contract, which does not have a set-aside designation, has a completion date of February 14, 2022 and was awarded on September 24, 2021. The place of performance is Scottsdale, Arizona....
- The Centers for Disease Control and Prevention awarded a $31 million firm fixed price contract to Biobot Analytics Inc. to provide commercial wastewater surveillance testing services in support of the National Wastewater Surveillance System. Under the terms of the contract, Biobot Analytics will quantitatively test wastewater samples twice weekly for SARS-CoV-2 and sequence qualifying samples over an 11-month period from April 2022 through February 2023. The contract is set aside for small...
- The Centers for Disease Control and Prevention (CDC) awarded a $41,290,502.86 firm-fixed-price definitive contract to Verily Life Sciences LLC, doing business as G L S, for wastewater surveillance testing. The contract has an ultimate completion date of August 6, 2026 and was awarded on January 12, 2024 without any set-aside designation. Verily Life Sciences, a subsidiary of Alphabet Inc., specializes in collecting, organizing, and activating health data, and has provided wastewater surveillance...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $5.6 million firm fixed price definitive contract to Verily Life Sciences LLC for wastewater surveillance testing. Under the contract, Verily Life Sciences will monitor wastewater samples to support the CDC's disease surveillance programs. The work will be performed by Verily Life Sciences in South San Francisco, California over a six-month period concluding in May 2024. No...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a purchase order contract to Soller Environmental, LLC, a small consulting firm, for wastewater surveillance services. The $134,985 time and materials contract supports COVID-19 monitoring efforts through wastewater surveillance modeling. As a subcontractor, Soller Environmental has also provided toxicological and microbial support services to the Environmental Protection Agency's Health and Ecological...
- This firm fixed price purchase order from the Department of Health and Human Services (HHS) awards Biobot Analytics Inc. $1.94 million to provide COVID-19 wastewater data testing services. The contract supports HHS' Office of the Assistant Secretary for Administration under the Coronavirus COVID-19 national interest code. Per the solicitation, Biobot will collect and test samples from at least 320 wastewater treatment facilities serving over 100 million U.S. citizens across all 50 states and...
- This is a $349,673 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents, for a project titled "BAA COVID WASTEWATER". The contract has no set-aside designation and has a period of performance through March 24, 2023. The University of Arizona is a public research university and 1862 land grant institution with expertise across various scientific and technical...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) has awarded a $240,756.00 firm-fixed-price purchase order to Zymo Research Corp., a minority-owned small business manufacturer located in Irvine, California. The contract is for wastewater sampling research under a Small Business Innovation Research (SBIR) program. Zymo Research will provide DNA sequencing, methylation profiling, and bioinformatics services to support the CDC's research initiatives in...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...